Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 86.7 USD -2.63% Market Closed
Market Cap: 5.5B USD
Have any thoughts about
Rhythm Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 85.09 USD with a low forecast of 72.72 USD and a high forecast of 98.7 USD.

Lowest
Price Target
72.72 USD
16% Downside
Average
Price Target
85.09 USD
2% Downside
Highest
Price Target
98.7 USD
14% Upside
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
PHM
Pharma Mar SA
18% Upside
TLX
Telix Pharmaceuticals Ltd
43% Upside
4593
Healios KK
9% Downside
TSHA
Taysha Gene Therapies Inc
204% Upside
SWTX
SpringWorks Therapeutics Inc
13% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
29% Upside
ORGO
Organogenesis Holdings Inc
48% Upside
4599
StemRIM Inc
134% Upside

Revenue
Forecast

Revenue Estimate
Rhythm Pharmaceuticals Inc

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 62%.

N/A
Past Growth
62%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
85.09 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 85.09 USD with a low forecast of 72.72 USD and a high forecast of 98.7 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
62%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 62%.

Back to Top